Analysts Press the ‘Buy’ Button on These 3 Under-the-Radar Stocks, , on October 20, 2020 at 4:59 pm

By
On October 20, 2020
Tags:

We’ve talked a lot about the economic downturn of this past spring and summer, and that’s a real story. The sequel, of course, is the remarkably fast recovery we’ve been experiencing, as first the stock market and then the general economy began bouncing back.The addendum to all of this, of course, is that there are stocks flashing ‘buy’ signs for investors. The reasons can vary, but at bottom, it’s fair to say that not every company suffered from coronavirus. For some, the new market conditions presented opportunities.Wall Street’s stock analysts make their reputations by spotting those opportunities – and letting the investing public know. We’ve opened the TipRanks database and pulled up three under-the-radar stocks that just received a thumbs-up from the analysts. There is upside here, along with some risk – but for investors willing to shoulder that, here are some unexpected picks from the Street.O’Reilly Automotive, Inc. (ORLY)One of the sectors that has seen positive growth in the ‘corona era’ is ‘do it yourself.’ DIY companies have found an expanding customer base as the social and economic isolation policies put in place to combat the virus closed businesses and forced people to stay home – but basic maintenance is still a requirement. O’Reilly is one such company. It sells aftermarket auto parts and supplies, including tools and accessories, to the DIY and professional market. The company boasts over 5,400 stores across the US and Mexico.American love their cars, and always have; home auto repair isn’t just a less expensive alternative to the shop, but also a popular hobby. O’Reilly has driven that basic fact to growing profits. The company saw $9.5 billion in total revenue in 2018, which grew to $10.2 billion 2019. So far, 2020 has seen $5.6 billion in revenue for the first half – and that number is trending up. Q1 saw $2.5 billion at the top line, while Q2 saw $3.1. Second quarter EPS was up 78% sequentially, to $7.10 per share.Indeed, the company credited an increased interest in DIY car repair for the strong quarter. Along with revenues and earnings, total sales were up 19%, comp store sales were up 16%, and net cash from operations grew by a whopping 84%, or $712 million.Matthew McClintock, writing from Raymond James, is unabashedly positive here. He says, “…we now believe that sizable independent market share is up for grabs now more than ever, and therefore we are incrementally positive on the company’s ability to deliver comps towards the higher end of its annual 3%-5% algorithm. This company remains and likely will remain the single best supply chain in this industry for the foreseeable future…”Along with this upbeat outlook, McClintock upgrades his rating on ORLY stock from Market Perform to Outperform (i.e. Buy), and his $550 target price represents an upside of 17%. (To watch McClintock’s track record, click here)Overall, ORLY has drawn optimism mixed with caution when it comes to consensus opinion among sell-side analysts. Out of 14 analysts polled in the last 3 months, 9 are bullish on ORLY stock, while 5 remain sidelined. With a 10% upside potential, the stock’s consensus target price stands at $517.31. (See ORLY stock analysis on TipRanks)Laird Superfood (LSF)The next stock on our list held its IPO just last month. Laird Superfood produces and markets a range of plant-based, nutrient-dense snacks and food additives. The company’s main line of products is specialized coffee creamers, designed to add both energy and nutrition to the morning staple.While LSF is too new to the public markets to have a significant chart history, and has not yet released quarterly results as a publicly traded company, it’s notable that the IPO was remarkably successful. The stock was offered for trading at $22 per share – but it opened at more than $33. The IPO sold more than 3 million common shares, and the company now boasts a market cap of $513 million.Canaccord analyst Robert Burleson is impressed with Laird, and initiates his firm’s coverage with a Buy rating and a $70 price target indicating room for 21% growth in the coming year. (To watch Burleson’s track record, click here)Supporting this view, Burleson writes, “LSF’s long-term prospects appear particularly attractive. The company is positioned to leverage its brand across an expansive range of plant-based foods. Backed by the wellness credibility of co-founders Laird Hamilton, an international fitness icon and nutrition expert, and his wife, Chief Brand Ambassador Gabrielle Reese, a professional volleyball player and model, LSF has already gained considerable traction within the plant-based, functional foods market.” In its short time on the public markets, LSF has garnered 3 Buy ratings, making the analyst consensus view a unanimous Strong Buy. Shares are selling for $53.58, and the average price target of $62.33 suggests a one-year upside of 8%. (See LSF stock analysis on TipRanks)CuriosityStream (CURI)Last on our list is CuriosityStream, an educational online video streaming channel devoted to ‘factual’ content. The site offers streaming services to subscribers, and boasts an audience of 13 million worldwide. It was first launched in 2015 by John Hendricks, who is best known for creating the Discovery Channel, the popular science-oriented cable channel, back in 1985.CuriosityStream went public at the end of the summer, through a merger deal with the ‘blank check’ special purpose acquisition company Software Acquisition. When the CURI ticker started trading earlier this month, on the NASDAQ exchange, it saw an almost immediate 10% price spike.The surge in interest in CURI was due in part to its public debut, but also to the company’s reputation and track record. CuriosityStream has received positive news coverage over the years from the New York Times, the LA Times, and the Wall Street Journal. It has also been nominated for 15 awards since 2016, for its science content and production quality, and has won 5 of those.Writing the first review on file for CURI shares is Zack Silver of B. Riley securities. He writes, “Our constructive view on CURI starts with a belief that consumers will continue to adopt SVOD as both a replacement and a complement to traditional linear TV… CURI launched its SVOD offering worldwide in 2015 and began to significantly ramp investments in marketing and content in 2018. Mr. Hendricks believes 40% of global viewers are interested in consuming factual programming; our recent survey work suggests that this number is closer to 80% in the U.S.” Silver initiates coverage of the stock with a Buy rating and a $16 price target that implies an impressive 45% one-year upside potential form the current share price of $11.02. (To watch Silver’s track record, click here)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.,

Analysts Press the ‘Buy’ Button on These 3 Under-the-Radar StocksWe’ve talked a lot about the economic downturn of this past spring and summer, and that’s a real story. The sequel, of course, is the remarkably fast recovery we’ve been experiencing, as first the stock market and then the general economy began bouncing back.The addendum to all of this, of course, is that there are stocks flashing ‘buy’ signs for investors. The reasons can vary, but at bottom, it’s fair to say that not every company suffered from coronavirus. For some, the new market conditions presented opportunities.Wall Street’s stock analysts make their reputations by spotting those opportunities – and letting the investing public know. We’ve opened the TipRanks database and pulled up three under-the-radar stocks that just received a thumbs-up from the analysts. There is upside here, along with some risk – but for investors willing to shoulder that, here are some unexpected picks from the Street.O’Reilly Automotive, Inc. (ORLY)One of the sectors that has seen positive growth in the ‘corona era’ is ‘do it yourself.’ DIY companies have found an expanding customer base as the social and economic isolation policies put in place to combat the virus closed businesses and forced people to stay home – but basic maintenance is still a requirement. O’Reilly is one such company. It sells aftermarket auto parts and supplies, including tools and accessories, to the DIY and professional market. The company boasts over 5,400 stores across the US and Mexico.American love their cars, and always have; home auto repair isn’t just a less expensive alternative to the shop, but also a popular hobby. O’Reilly has driven that basic fact to growing profits. The company saw $9.5 billion in total revenue in 2018, which grew to $10.2 billion 2019. So far, 2020 has seen $5.6 billion in revenue for the first half – and that number is trending up. Q1 saw $2.5 billion at the top line, while Q2 saw $3.1. Second quarter EPS was up 78% sequentially, to $7.10 per share.Indeed, the company credited an increased interest in DIY car repair for the strong quarter. Along with revenues and earnings, total sales were up 19%, comp store sales were up 16%, and net cash from operations grew by a whopping 84%, or $712 million.Matthew McClintock, writing from Raymond James, is unabashedly positive here. He says, “…we now believe that sizable independent market share is up for grabs now more than ever, and therefore we are incrementally positive on the company’s ability to deliver comps towards the higher end of its annual 3%-5% algorithm. This company remains and likely will remain the single best supply chain in this industry for the foreseeable future…”Along with this upbeat outlook, McClintock upgrades his rating on ORLY stock from Market Perform to Outperform (i.e. Buy), and his $550 target price represents an upside of 17%. (To watch McClintock’s track record, click here)Overall, ORLY has drawn optimism mixed with caution when it comes to consensus opinion among sell-side analysts. Out of 14 analysts polled in the last 3 months, 9 are bullish on ORLY stock, while 5 remain sidelined. With a 10% upside potential, the stock’s consensus target price stands at $517.31. (See ORLY stock analysis on TipRanks)Laird Superfood (LSF)The next stock on our list held its IPO just last month. Laird Superfood produces and markets a range of plant-based, nutrient-dense snacks and food additives. The company’s main line of products is specialized coffee creamers, designed to add both energy and nutrition to the morning staple.While LSF is too new to the public markets to have a significant chart history, and has not yet released quarterly results as a publicly traded company, it’s notable that the IPO was remarkably successful. The stock was offered for trading at $22 per share – but it opened at more than $33. The IPO sold more than 3 million common shares, and the company now boasts a market cap of $513 million.Canaccord analyst Robert Burleson is impressed with Laird, and initiates his firm’s coverage with a Buy rating and a $70 price target indicating room for 21% growth in the coming year. (To watch Burleson’s track record, click here)Supporting this view, Burleson writes, “LSF’s long-term prospects appear particularly attractive. The company is positioned to leverage its brand across an expansive range of plant-based foods. Backed by the wellness credibility of co-founders Laird Hamilton, an international fitness icon and nutrition expert, and his wife, Chief Brand Ambassador Gabrielle Reese, a professional volleyball player and model, LSF has already gained considerable traction within the plant-based, functional foods market.” In its short time on the public markets, LSF has garnered 3 Buy ratings, making the analyst consensus view a unanimous Strong Buy. Shares are selling for $53.58, and the average price target of $62.33 suggests a one-year upside of 8%. (See LSF stock analysis on TipRanks)CuriosityStream (CURI)Last on our list is CuriosityStream, an educational online video streaming channel devoted to ‘factual’ content. The site offers streaming services to subscribers, and boasts an audience of 13 million worldwide. It was first launched in 2015 by John Hendricks, who is best known for creating the Discovery Channel, the popular science-oriented cable channel, back in 1985.CuriosityStream went public at the end of the summer, through a merger deal with the ‘blank check’ special purpose acquisition company Software Acquisition. When the CURI ticker started trading earlier this month, on the NASDAQ exchange, it saw an almost immediate 10% price spike.The surge in interest in CURI was due in part to its public debut, but also to the company’s reputation and track record. CuriosityStream has received positive news coverage over the years from the New York Times, the LA Times, and the Wall Street Journal. It has also been nominated for 15 awards since 2016, for its science content and production quality, and has won 5 of those.Writing the first review on file for CURI shares is Zack Silver of B. Riley securities. He writes, “Our constructive view on CURI starts with a belief that consumers will continue to adopt SVOD as both a replacement and a complement to traditional linear TV… CURI launched its SVOD offering worldwide in 2015 and began to significantly ramp investments in marketing and content in 2018. Mr. Hendricks believes 40% of global viewers are interested in consuming factual programming; our recent survey work suggests that this number is closer to 80% in the U.S.” Silver initiates coverage of the stock with a Buy rating and a $16 price target that implies an impressive 45% one-year upside potential form the current share price of $11.02. (To watch Silver’s track record, click here)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

,

Instant Quote

Enter the Stock Symbol.

Select the Exchange.

Select the Type of Security.

Please enter your First Name.

Please enter your Last Name.

Please enter your phone number.

Please enter your Email Address.

Please enter or select the Total Number of Shares you own.

Please enter or select the Desired Loan Amount you are seeking.

Please select the Loan Purpose.

Please select if you are an Officer/Director.

High West Capital Partners, LLC may only offer certain information to persons who are “Accredited Investors” and/or “Qualified Clients” as those terms are defined under applicable Federal Securities Laws. In order to be an “Accredited Investor” and/or a “Qualified Client”, you must meet the criteria identified in ONE OR MORE of the following categories/paragraphs numbered 1-20 below.

High West Capital Partners, LLC cannot provide you with any information regarding its Loan Programs or Investment Products unless you meet one or more of the following criteria. Furthermore, Foreign nationals who may be exempt from qualifying as a U.S. Accredited Investor are still required to meet the established criteria, in accordance with High West Capital Partners, LLC’s internal lending policies. High West Capital Partners, LLC will not provide information or lend to any individual and/or entity that does not meet one or more of the following criteria:

1) Individual with Net Worth in excess of $1.0 million. A natural person (not an entity) whose net worth, or joint net worth with his or her spouse, at the time of purchase exceeds $1,000,000 USD. (In calculating net worth, you may include your equity in personal property and real estate, including your principal residence, cash, short-term investments, stock and securities. Your inclusion of equity in personal property and real estate should be based on the fair market value of such property less debt secured by such property.)

2) Individual with $200,000 individual Annual Income. A natural person (not an entity) who had individual income of more than $200,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

3) Individual with $300,000 Joint Annual Income. A natural person (not an entity) who had joint income with his or her spouse in excess of $300,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

4) Corporations or Partnerships. A corporation, partnership, or similar entity that has in excess of $5 million of assets and was not formed for the specific purpose of acquiring an interest in the Corporation or Partnership.

5) Revocable Trust. A trust that is revocable by its grantors and each of whose grantors is an Accredited Investor as defined in one or more of the other categories/paragraphs numbered herein.

6) Irrevocable Trust. A trust (other than an ERISA plan) that (a)is not revocable by its grantors, (b) has in excess of $5 million of assets, (c) was not formed for the specific purpose of acquiring an interest, and (d) is directed by a person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of an investment in the Trust.

7) IRA or Similar Benefit Plan. An IRA, Keogh or similar benefit plan that covers only a single natural person who is an Accredited Investor, as defined in one or more of the other categories/paragraphs numbered herein.

8) Participant-Directed Employee Benefit Plan Account. A participant-directed employee benefit plan investing at the direction of, and for the account of, a participant who is an Accredited Investor, as that term is defined in one or more of the other categories/paragraphs numbered herein.

9) Other ERISA Plan. An employee benefit plan within the meaning of Title I of the ERISA Act other than a participant-directed plan with total assets in excess of $5 million or for which investment decisions (including the decision to purchase an interest) are made by a bank, registered investment adviser, savings and loan association, or insurance company.

10) Government Benefit Plan. A plan established and maintained by a state, municipality, or any agency of a state or municipality, for the benefit of its employees, with total assets in excess of $5 million.

11) Non-Profit Entity. An organization described in Section 501(c)(3) of the Internal Revenue Code, as amended, with total assets in excess of $5 million (including endowment, annuity and life income funds), as shown by the organization’s most recent audited financial statements.

12) A bank, as defined in Section 3(a)(2) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

13) A savings and loan association or similar institution, as defined in Section 3(a)(5)(A) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

14) A broker-dealer registered under the Exchange Act.

15) An insurance company, as defined in Section 2(13) of the Securities Act.

16) A “business development company,” as defined in Section 2(a)(48) of the Investment Company Act.

17) A small business investment company licensed under Section 301 (c) or (d) of the Small Business Investment Act of 1958.

18) A “private business development company” as defined in Section 202(a)(22) of the Advisers Act.

19) Executive Officer or Director. A natural person who is an executive officer, director or general partner of the Partnership or the General Partner, and is an Accredited Investor as that term is defined in one or more of the categories/paragraphs numbered herein.

20) Entity Owned Entirely By Accredited Investors. A corporation, partnership, private investment company or similar entity each of whose equity owners is a natural person who is an Accredited Investor, as that term is defined in one or more of the categories/paragraphs numbered herein.

Please read the notice above and check the box below to continue.

Singapore

168 Robinson Road,
Capital Tower, Singapore 068912
+65 3105 1295

Taiwan

5th Floor, No. 1-8, Section 5, Zhongxiao East Road, Taipei

Hong Kong

R91, 3rd Floor,
Eton Tower, 8 Hysan Ave.
Causeway Bay, Hong Kong
+852 3002 4462

Australia

44 Martin Place, Sydney 2000 Australia
+02 8319 3232

Indonesia

Millennium Centennial Center, 38th Floor, Jl. Jend. Sudirman Kav. 25
Jakarta 12920, Indonesia

Market Coverage